vs
HARVARD BIOSCIENCE INC（HBIO）与沃特世（WAT）财务数据对比。点击上方公司名可切换其他公司
沃特世的季度营收约是HARVARD BIOSCIENCE INC的39.3倍（$932.4M vs $23.7M）。沃特世净利率更高（24.2% vs -12.0%，领先36.2%）。沃特世同比增速更快（6.8% vs -3.3%）。过去两年沃特世的营收复合增速更高（21.0% vs -1.6%）
哈佛生物科学是一家全球生命科学设备开发商、制造商与销售商，其产品主要用于支撑科研开发与药物研发工作，目前该公司在纳斯达克上市，股票交易代码为HBIO。
沃特世是总部位于美国马萨诸塞州米尔福德的企业，面向生命科学、材料、食品等行业，提供色谱、质谱、实验室信息学、流变测量领域所用的分析仪器及配套软件，为各领域的检测、研发等工作提供可靠技术支持。
HBIO vs WAT — 直观对比
营收规模更大
WAT
是对方的39.3倍
$23.7M
营收增速更快
WAT
高出10.2%
-3.3%
净利率更高
WAT
高出36.2%
-12.0%
两年增速更快
WAT
近两年复合增速
-1.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $23.7M | $932.4M |
| 净利润 | $-2.8M | $225.2M |
| 毛利率 | 59.7% | 61.1% |
| 营业利润率 | 7.2% | 29.0% |
| 净利率 | -12.0% | 24.2% |
| 营收同比 | -3.3% | 6.8% |
| 净利润同比 | -15916.7% | -2.7% |
| 每股收益（稀释后） | $-0.06 | $3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBIOWAT
| Q4 25 | $23.7M | $932.4M | ||
| Q3 25 | $20.6M | $799.9M | ||
| Q2 25 | $20.4M | $771.3M | ||
| Q1 25 | $21.8M | $661.7M | ||
| Q4 24 | $24.6M | $872.7M | ||
| Q3 24 | $22.0M | $740.3M | ||
| Q2 24 | $23.1M | $708.5M | ||
| Q1 24 | $24.5M | $636.8M |
净利润HBIOWAT
| Q4 25 | $-2.8M | $225.2M | ||
| Q3 25 | $-1.2M | $148.9M | ||
| Q2 25 | $-2.3M | $147.1M | ||
| Q1 25 | $-50.3M | $121.4M | ||
| Q4 24 | $18.0K | $231.4M | ||
| Q3 24 | $-4.8M | $161.5M | ||
| Q2 24 | $-2.9M | $142.7M | ||
| Q1 24 | $-4.7M | $102.2M |
毛利率HBIOWAT
| Q4 25 | 59.7% | 61.1% | ||
| Q3 25 | 58.4% | 59.0% | ||
| Q2 25 | 56.4% | 58.3% | ||
| Q1 25 | 56.0% | 58.2% | ||
| Q4 24 | 57.1% | 60.1% | ||
| Q3 24 | 58.1% | 59.3% | ||
| Q2 24 | 57.2% | 59.3% | ||
| Q1 24 | 60.3% | 58.9% |
营业利润率HBIOWAT
| Q4 25 | 7.2% | 29.0% | ||
| Q3 25 | 1.0% | 24.0% | ||
| Q2 25 | -4.0% | 24.4% | ||
| Q1 25 | -228.1% | 22.9% | ||
| Q4 24 | 0.0% | 33.5% | ||
| Q3 24 | -8.5% | 28.5% | ||
| Q2 24 | -9.0% | 26.7% | ||
| Q1 24 | -9.3% | 21.0% |
净利率HBIOWAT
| Q4 25 | -12.0% | 24.2% | ||
| Q3 25 | -6.0% | 18.6% | ||
| Q2 25 | -11.2% | 19.1% | ||
| Q1 25 | -231.2% | 18.3% | ||
| Q4 24 | 0.1% | 26.5% | ||
| Q3 24 | -21.9% | 21.8% | ||
| Q2 24 | -12.7% | 20.1% | ||
| Q1 24 | -19.1% | 16.0% |
每股收益（稀释后）HBIOWAT
| Q4 25 | $-0.06 | $3.76 | ||
| Q3 25 | $-0.03 | $2.50 | ||
| Q2 25 | $-0.05 | $2.47 | ||
| Q1 25 | $-1.14 | $2.03 | ||
| Q4 24 | $0.01 | $3.88 | ||
| Q3 24 | $-0.11 | $2.71 | ||
| Q2 24 | $-0.07 | $2.40 | ||
| Q1 24 | $-0.11 | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $587.8M |
| 总债务越低越好 | $35.9M | $1.4B |
| 股东权益账面价值 | $13.7M | $2.6B |
| 总资产 | $80.1M | $5.1B |
| 负债/权益比越低杠杆越低 | 2.61× | 0.55× |
8季度趋势，按日历期对齐
现金及短期投资HBIOWAT
| Q4 25 | $8.6M | $587.8M | ||
| Q3 25 | $6.8M | $459.1M | ||
| Q2 25 | $7.4M | $367.2M | ||
| Q1 25 | $5.5M | $382.9M | ||
| Q4 24 | $4.1M | $325.4M | ||
| Q3 24 | $4.6M | $331.5M | ||
| Q2 24 | $4.0M | $327.4M | ||
| Q1 24 | $4.3M | $338.2M |
总债务HBIOWAT
| Q4 25 | $35.9M | $1.4B | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $34.9M | — | ||
| Q1 25 | $36.4M | — | ||
| Q4 24 | $37.0M | $1.6B | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.6M | — |
股东权益HBIOWAT
| Q4 25 | $13.7M | $2.6B | ||
| Q3 25 | $14.1M | $2.3B | ||
| Q2 25 | $15.7M | $2.2B | ||
| Q1 25 | $14.8M | $2.0B | ||
| Q4 24 | $63.3M | $1.8B | ||
| Q3 24 | $65.3M | $1.6B | ||
| Q2 24 | $67.2M | $1.4B | ||
| Q1 24 | $68.8M | $1.3B |
总资产HBIOWAT
| Q4 25 | $80.1M | $5.1B | ||
| Q3 25 | $78.0M | $4.9B | ||
| Q2 25 | $80.1M | $4.7B | ||
| Q1 25 | $79.8M | $4.6B | ||
| Q4 24 | $126.6M | $4.6B | ||
| Q3 24 | $131.2M | $4.5B | ||
| Q2 24 | $128.9M | $4.4B | ||
| Q1 24 | $133.2M | $4.5B |
负债/权益比HBIOWAT
| Q4 25 | 2.61× | 0.55× | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 0.58× | 0.89× | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.52× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.0K | $164.6M |
| 自由现金流经营现金流 - 资本支出 | $-545.0K | — |
| 自由现金流率自由现金流/营收 | -2.3% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.73× |
| 过去12个月自由现金流最近4个季度 | $5.5M | — |
8季度趋势，按日历期对齐
经营现金流HBIOWAT
| Q4 25 | $-96.0K | $164.6M | ||
| Q3 25 | $1.1M | $187.3M | ||
| Q2 25 | $2.8M | $41.1M | ||
| Q1 25 | $3.0M | $259.6M | ||
| Q4 24 | $1.7M | $240.1M | ||
| Q3 24 | $-842.0K | $204.6M | ||
| Q2 24 | $-846.0K | $54.5M | ||
| Q1 24 | $1.4M | $262.9M |
自由现金流HBIOWAT
| Q4 25 | $-545.0K | — | ||
| Q3 25 | $877.0K | — | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.7M | — | ||
| Q1 24 | $758.0K | — |
自由现金流率HBIOWAT
| Q4 25 | -2.3% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | -7.8% | — | ||
| Q2 24 | -7.2% | — | ||
| Q1 24 | 3.1% | — |
资本支出强度HBIOWAT
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 2.6% | — |
现金转化率HBIOWAT
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 2.14× | ||
| Q4 24 | 95.83× | 1.04× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 2.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
WAT
暂无分部数据
